M Fanin Selected Research

Proteins (Proteins, Gene)

12/2013	Muscle atrophy in Limb Girdle Muscular Dystrophy 2A: a morphometric and molecular study.
4/2009	Frequency of LGMD gene mutations in Italian patients with distinct clinical phenotypes.
1/2007	Screening of calpain-3 autolytic activity in LGMD muscle: a functional map of CAPN3 gene mutations.
4/2006	Early onset calpainopathy with normal non-functional calpain 3 level.
7/2004	Molecular diagnosis in LGMD2A: mutation analysis or protein testing?
3/2001	Calpain-3 and dysferlin protein screening in patients with limb-girdle dystrophy and myopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Fanin Research Topics

Disease

8	Muscular Diseases (Myopathy) 12/2019 - 01/2000
6	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 08/2016 - 03/2001
5	Limb-girdle muscular dystrophy type 2A 08/2016 - 07/2004
4	Atrophy 12/2013 - 01/2000
3	Dysferlinopathy 07/2011 - 12/2002
3	Muscular Dystrophies (Muscular Dystrophy) 06/2002 - 01/2000
2	Inflammation (Inflammations) 08/2016 - 12/2002
2	type 2B Limb-girdle muscular dystrophy 08/2016 - 02/2005
2	Protein Deficiency 07/2004 - 03/2001
2	Cardiomyopathies (Cardiomyopathy) 05/2003 - 02/2001
2	Sarcoglycanopathies 05/2003 - 01/2000
2	Distal Myopathies (Distal Muscular Dystrophy) 12/2002 - 03/2001
1	Heart Failure 01/2020
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 12/2019
1	Lafora Disease 12/2019
1	Glycogen Storage Disease (Glycogenosis) 12/2019
1	Glycogen Storage Disease Type IV (Andersen's Disease) 12/2019
1	Glycogen Storage Disease Type VII (Tarui's Disease) 12/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 12/2019
1	Muscular Atrophy (Muscle Atrophy) 12/2013
1	Myasthenia Gravis 02/2009
1	Myotonic Dystrophy (Dystrophia Myotonica) 10/2005
1	Miyoshi myopathy 02/2005
1	Necrosis 12/2002
1	Seizures (Absence Seizure) 10/2000
1	Muscle Hypotonia (Hypotonia) 10/2000
1	Muscle Weakness 10/2000
1	Myotoxicity 01/2000
1	Massive Hepatic Necrosis 01/2000
1	Paralysis (Palsy) 01/2000

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 12/2013 - 03/2001
4	DysferlinIBA 07/2011 - 03/2001
3	Sarcoglycans (beta Sarcoglycan)IBA 05/2003 - 01/2000
2	CalpainIBA 04/2009 - 04/2006
2	AntibodiesIBA 02/2009 - 12/2002
1	polyglucosanIBA 12/2019
1	AmylopectinIBA 12/2019
1	GlycogenIBA 12/2019
1	Polysaccharides (Glycans)IBA 12/2019
1	Carrier Proteins (Binding Protein)IBA 08/2016
1	Peptides (Polypeptides)IBA 08/2016
1	CalciumIBA 08/2016
1	MicroRNAs (MicroRNA)IBA 08/2016
1	Guanine NucleotidesIBA 08/2016
1	Calcitriol Receptors (Calcitriol Receptor)IBA 08/2016
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 01/2016
1	UbiquitinIBA 12/2013
1	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2013
1	Protein AggregatesIBA 10/2012
1	Messenger RNA (mRNA)IBA 07/2011
1	DNA (Deoxyribonucleic Acid)IBA 07/2011
1	Phosphotransferases (Kinase)IBA 02/2009
1	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 02/2009
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 02/2009
1	muskIBA 02/2009
1	Muscle Proteins (Muscle Protein)IBA 04/2006
1	Myotonin-Protein KinaseIBA 10/2005
1	CytosineIBA 10/2005
1	GuanineIBA 10/2005
1	ThymineIBA 10/2005
1	3' Untranslated Regions (3' UTR)IBA 10/2005
1	Peptide Hydrolases (Proteases)FDA Link 07/2004
1	Creatine Kinase (Creatine Phosphokinase)IBA 07/2004
1	Histocompatibility Antigens Class IIBA 12/2002
1	Laminin (Merosin)IBA 10/2000
1	Protein Isoforms (Isoforms)IBA 10/2000
1	Myosins (Myosin)IBA 01/2000
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2000
1	DesminIBA 01/2000
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2000

Therapy/Procedure

2	Heart Transplantation (Grafting, Heart) 01/2020 - 02/2001
1	Mechanical Ventilators (Ventilator) 01/2000
1	Liver Transplantation 01/2000